Taigen Biopharmaceuticals Holdings Ltd (4157)

Currency in TWD
8.28
-0.01(-0.12%)
Closed·
4157 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4157 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.138.42
52 wk Range
7.4415.15
Key Statistics
Bid/Ask
19.85 / 19.90
Prev. Close
10.6
Open
8.42
Day's Range
8.13-8.42
52 wk Range
7.44-15.15
Volume
346.62K
Average Volume (3m)
764.64K
1-Year Change
-37.9%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4157 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Taigen Biopharmaceuticals Holdings Ltd Company Profile

TaiGen Biopharmaceuticals Holdings Limited, a pharmaceutical company, develops novel therapeutics for transformative diseases worldwide. The company develops Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic for the treatment of bacterial infections. Its product pipeline comprises Taigexyn, which is in phase II clinical trial for the treatment of community-acquired pneumonia/diabetic foot infection; TG-1000, which is in phase III clinical trial to treat influenza A and B, and avian influenza H7N9; Furaprevir, a HCV protease inhibitor for the treatment of chronic hepatitis C; and Burixafor, a stem cell mobilizer which is in phase II clinical trial for stem cell transplantation and chemosenzitization. In addition, the company is involved in the provision of consultation on pharmaceutical technology; and manufacture and sale of health food. The company was founded in 2001 and is based in Taipei City, Taiwan.

0
Market
Taiwan

Compare 4157 to Peers and Sector

Metrics to compare
4157
Peers
Sector
Relationship
P/E Ratio
−107.9x−24.4x−0.5x
PEG Ratio
0.830.020.00
Price/Book
5.7x2.7x2.6x
Price / LTM Sales
39.2x30.1x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock−17.4%6.9%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
10.88M / --
EPS Revisions
Last 90 days

4157 Income Statement

FAQ

What Stock Exchange Does Taigen BioPharmas Trade On?

Taigen BioPharmas is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Taigen BioPharmas?

The stock symbol for Taigen BioPharmas is "4157."

What Is the Taigen BioPharmas Market Cap?

As of today, Taigen BioPharmas market cap is 5.87B.

What Is Taigen BioPharmas's Earnings Per Share (TTM)?

The Taigen BioPharmas EPS (TTM) is -0.08.

When Is the Next Taigen BioPharmas Earnings Date?

Taigen BioPharmas will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is 4157 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Taigen BioPharmas Stock Split?

Taigen BioPharmas has split 1 times.

How Many Employees Does Taigen BioPharmas Have?

Taigen BioPharmas has 0 employees.

What is the current trading status of Taigen BioPharmas (4157)?

As of 07 Aug 2025, Taigen BioPharmas (4157) is trading at a price of 8.28, with a previous close of 10.60. The stock has fluctuated within a day range of 8.13 to 8.42, while its 52-week range spans from 7.44 to 15.15.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.